Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Stocks Up After Powell Comments
Ed Siddell, CEO and chief investment officer of EGSI Financial, joined Cheddar News to discuss Tuesday's market session as stocks traded higher after Fed Chair Jerome Powell gave a favorable glimpse into disinflation.
Load More